We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Unilever
UL
$136B
| $114M | 0.27% |
1,772,457
-1,420,662
| -44% | -$94.4M |
|
77
MarketAxess Holdings
MKTX
$5.72B
| $112M | 0.26% |
294,883
+113,564
| +63% | +$41.7M |
|
78
Jabil
JBL
$35.8B
| $111M | 0.26% |
2,675,236
+1,902,353
| +246% | +$73M |
|
79
Brunswick
BC
$5.28B
| $110M | 0.26% |
1,840,022
+1,264,894
| +220% | +$73.2M |
|
|
CNH
80
CNH Industrial
CNH
$17.5B
| $110M | 0.26% |
11,486,371
-506,358
| -4% | -$4.76M |
|
81
L3Harris
LHX
$53.4B
| $101M | 0.24% |
511,209
+250,348
| +96% | +$50.2M |
|
82
Gentex
GNTX
$5.07B
| $100M | 0.23% |
3,464,074
+1,737,804
| +101% | +$48.9M |
|
83
Ralph Lauren
RL
$23.6B
| $98.8M | 0.23% |
842,577
-120,402
| -13% | -$12.7M |
|
84
Keysight
KEYS
$58.3B
| $97.1M | 0.23% |
946,300
+193,667
| +26% | +$19.8M |
|
85
RH
RH
$3.71B
| $96.9M | 0.23% |
453,733
+92,453
| +26% | +$18M |
|
86
Nutrien
NTR
$30.7B
| $96.9M | 0.23% |
2,022,289
+1,866,500
| +1,198% | +$90.2M |
|
|
CIT
87
DELISTED
CIT Group Inc.
CIT
| $94.9M | 0.22% |
2,078,814
+797,942
| +62% | +$35.7M |
|
88
ASML
ASML
$669B
| $94.8M | 0.22% |
320,350
+286,650
| +851% | +$77.4M |
|
89
Viatris
VTRS
$18.9B
| $94.5M | 0.22% |
4,702,226
+2,961,668
| +170% | +$55.1M |
|
|
90
Union Pacific
UNP
$174B
| $91.3M | 0.21% |
505,030
-1,923,183
| -79% | -$329M |
|
91
Intercontinental Exchange
ICE
$84.4B
| $91.2M | 0.21% |
985,073
+660,735
| +204% | +$61.3M |
|
92
Jazz Pharmaceuticals
JAZZ
$16.7B
| $89.8M | 0.21% |
601,252
+165,144
| +38% | +$22.5M |
|
93
Apple
AAPL
$4.57T
| $89.4M | 0.21% |
1,217,916
+744,392
| +157% | +$47.9M |
|
94
Ciena
CIEN
$58.4B
| $89.4M | 0.21% |
2,093,873
+630,727
| +43% | +$24M |
|
95
Dick's Sporting Goods
DKS
$18.7B
| $89.3M | 0.21% |
+1,805,131
| New | +$76.8M |
|
96
Bath & Body Works
BBWI
$4.1B
| $88.1M | 0.2% |
6,015,034
+4,615,493
| +330% | +$66.6M |
|
|
DFS
97
DELISTED
Discover Financial Services
DFS
| $88.1M | 0.2% |
1,038,279
-246,552
| -19% | -$20.3M |
|
98
Cirrus Logic
CRUS
$6.26B
| $87.4M | 0.2% |
1,060,871
-59,993
| -5% | -$4.06M |
|
99
Goodyear
GT
$1.85B
| $86.1M | 0.2% |
5,534,018
-258,782
| -4% | -$4.04M |
|
100
Monster Beverage
MNST
$88.5B
| $85.9M | 0.2% |
2,703,458
-2,265,362
| -46% | -$66.5M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.